Coronavirus Update: US FDA Panel To Review J&J’s Vaccine On 26 February

Plus: Daiichi Signs Japan Deal With AZ

 
• By Scrip Team
J&J Covid vaccine
J&J's vaccine, named Ad26.COV2.S, could gain an emergency use authorization on 26 February.

More from COVID-19

More from Scrip